CR: | BRD3 | |
Accession: | Q15059 | |
Protein names: | Bromodomain-containing protein 3 short isoform | |
Function type: | Histone Modifier | |
Histone type: | Reader | |
Methytor type: | Unkown | |
Aliases: | Bromo-PHD | |
PMID: | 32895492 21536911 34482332 | |
Disease: | 8 | |
Go term: | 5 | |
Pathway: | -- | |
Hallmark: | -- | |
Super Enhancer: | chr9:136904463-136934225 chr9:136913824-136934451 chr9:136909120-136944082 chr9:136917526-136934650 chr9:136918029-136934417 chr9:136904848-136932503 chr9:136913423-136922260 chr9:136889544-136944540 chr9:136893678-136934356 chr9:136893397-136934497 chr9:136893775-136935570 |
|
Enhancer: |
chr9:136814680-136817100 chr9:136890660-136890960 chr9:136891210-136891320 chr9:136335910-136336210 chr9:136341460-136342150 chr9:136400040-136401680 chr9:136644010-136645030 chr9:136645060-136645810 chr9:136649540-136650890 chr9:136912040-136912550 chr9:136912590-136912860 chr9:136601840-136603370 chr9:136678620-136680830 chr9:136724760-136726490 chr9:136729820-136730020 chr9:136750370-136750970 chr9:136924300-136926040 chr9:136926190-136928560 chr9:136929880-136930390 chr9:137027180-137029560 chr9:136854720-136857190 chr9:136913580-136915490 chr9:136915710-136916680 chr9:136905400-136906880 chr9:136790350-136792840 chr9:136812170-136814340 chr9:136823880-136824630 chr9:136825450-136826420 chr9:136833010-136834750 chr9:136272200-136272930 chr9:137021720-137023010 chr9:137326050-137328310 chr9:136527530-136528680 chr9:137005930-137006630 chr9:136704260-136706470 chr9:136762110-136764150 chr9:136566080-136568030 chr9:136771360-136771580 chr9:136771750-136773420 chr9:136776650-136777000 chr9:136782130-136783940 chr9:136707020-136707550 chr9:136738200-136740700 chr9:137243480-137245850 chr9:137245870-137247340 chr9:137250120-137251040 chr9:137251240-137251920 chr9:137261150-137262690 chr9:137265650-137266140 chr9:137299340-137299990 chr9:137300150-137300780 chr9:137300970-137303290 chr9:137304910-137307040 chr9:137248360-137249500 chr9:136342360-136343370 chr9:136409670-136412150 chr9:136439110-136439860 chr9:136568150-136570060 chr9:136641710-136642510 chr9:136642590-136643880 chr9:136648710-136649430 chr9:136653610-136654370 chr9:136654470-136656900 chr9:135960430-135961640 chr9:136834990-136836080 chr9:136613500-136615990 chr9:136619700-136620280 chr9:136683520-136684370 chr9:136719590-136719800 chr9:137323840-137325940 chr9:137338030-137340300 chr9:137340650-137343100 chr9:137368220-137368700 chr9:137393590-137395970 chr9:136740930-136742680 chr9:137481970-137482830 chr9:137483190-137484970 chr9:137514660-137515870 chr9:137516510-137517420 chr9:137518330-137518850 chr9:137534140-137536140 chr9:137396180-137396870 chr9:137493410-137495270 chr9:136547920-136550240 chr9:136599330-136601550 chr9:137307390-137309000 chr9:137276430-137278900 chr9:137279990-137281260 chr9:136638790-136640050 chr9:136734310-136735970 chr9:136871950-136873020 chr9:136917680-136918380 chr9:137016110-137016520 |
|
Promoter: |
chr9:134066535-134070535 |
Sample ID | CR | Biosample type | Biosample term name | File accession | Experiment accession | Source |
---|---|---|---|---|---|---|
CR_02_0014 | BRD3 | cell line | MM1.S | SRR1015260 | GSE43743 | GEO |
CR_02_0194 | BRD3 | cell line | HCT116 | SRR11969128 | GSE152144 | GEO |
CR_02_0195 | BRD3 | cell line | HCT116 | SRR11969129 | GSE152144 | GEO |
CR_02_0303 | BRD3 | cell line | LX-2 | SRR1427129 | GSE58680 | GEO |
CR_02_0356 | BRD3 | cell line | H9 | SRR1537742 | GSE60171 | GEO |
CR_02_0357 | BRD3 | cell line | H9 | SRR1537743 | GSE60171 | GEO |
CR_02_0503 | BRD3 | cell line | MutuI | SRR3822410 | GSE84214 | GEO |
CR_02_0504 | BRD3 | cell line | MutuI | SRR3822411 | GSE84213 | GEO |
CR_02_0768 | BRD3 | cell line | MCF-7 | SRR6507229 | GSE109572/GSE109571 | GEO |
CR_02_0769 | BRD3 | cell line | MCF-7 | SRR6507230 | GSE109572/GSE109571 | GEO |
CR_02_0770 | BRD3 | cell line | MCF-7 | SRR6507231 | GSE109572/GSE109571 | GEO |
CR_02_0771 | BRD3 | cell line | MCF-7 | SRR6507232 | GSE109572/GSE109571 | GEO |
CR_02_0783 | BRD3 | cell line | liposarcoma cells | SRR6792591 | GSE111254/GSE111253 | GEO |
CR_02_0913 | BRD3 | cell line | A549 | SRR7822628 | GSE119863 | GEO |
CR_02_0942 | BRD3 | Tissue | Chronic Myelogenous Leukemia | SRR7947485 | GSE120715 | GEO |
CR_02_0943 | BRD3 | Tissue | Chronic Myelogenous Leukemia | SRR7947486 | GSE120715 | GEO |
CR_02_0944 | BRD3 | Tissue | Chronic Myelogenous Leukemia | SRR7947487 | GSE120715 | GEO |
CR_02_0945 | BRD3 | Tissue | Chronic Myelogenous Leukemia | SRR7947488 | GSE120715 | GEO |
CR_02_0946 | BRD3 | Tissue | Chronic Myelogenous Leukemia | SRR7947489 | GSE120715 | GEO |
CR_02_0947 | BRD3 | Tissue | Chronic Myelogenous Leukemia | SRR7947490 | GSE120715 | GEO |
CR_02_0948 | BRD3 | Tissue | Chronic Myelogenous Leukemia | SRR7947491 | GSE120715 | GEO |
CR_02_0949 | BRD3 | Tissue | Chronic Myelogenous Leukemia | SRR7947492 | GSE120715 | GEO |
CR_02_0950 | BRD3 | Tissue | Biphenotypic B Myelomonocytic Leukemia | SRR7947493 | GSE120715 | GEO |
CR_02_0951 | BRD3 | Tissue | Biphenotypic B Myelomonocytic Leukemia | SRR7947494 | GSE120715 | GEO |
CR_02_0952 | BRD3 | Tissue | Biphenotypic B Myelomonocytic Leukemia | SRR7947495 | GSE120715 | GEO |
CR_02_0953 | BRD3 | Tissue | Biphenotypic B Myelomonocytic Leukemia | SRR7947496 | GSE120715 | GEO |
CR_02_0954 | BRD3 | Tissue | Biphenotypic B Myelomonocytic Leukemia | SRR7947497 | GSE120715 | GEO |
CR_02_0955 | BRD3 | Tissue | Biphenotypic B Myelomonocytic Leukemia | SRR7947498 | GSE120715 | GEO |
CR_02_0956 | BRD3 | Tissue | Biphenotypic B Myelomonocytic Leukemia | SRR7947499 | GSE120715 | GEO |
CR_02_0957 | BRD3 | Tissue | Biphenotypic B Myelomonocytic Leukemia | SRR7947500 | GSE120715 | GEO |
CR_02_1447 | BRD3 | cell line | MM1.S | SRR1015258 | GSE43743 | GEO |
CR_02_1448 | BRD3 | cell line | MM1.S | SRR1015259 | GSE43743 | GEO |
CR_02_1502 | BRD3 | cell line | LX-2 | SRR1427128 | GSE58680 | GEO |